Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Faces Capital Efficiency Challenges

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) is a dermatology therapeutics company focused on developing and commercializing treatments for skin diseases. The company is currently facing challenges in capital efficiency, as indicated by its financial metrics. A key measure of this efficiency is the comparison of Return on Invested Capital (ROIC) to Weighted Average Cost of Capital (WACC).Verrica's ROIC stands at -65.23%, which is significantly lower than its WACC of 15.85%. This results in a ROIC to WACC rati ...